Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells.
Dáňová K, Grohová A, Strnadová P, Funda DP, Šumník Z, Lebl J, Cinek O, Průhová Š, Koloušková S, Obermannová B, Petruželková L, Šedivá A, Fundová P, Buschard K, Špíšek R, Palová-Jelínková L. Dáňová K, et al. J Immunol. 2017 Jan 15;198(2):729-740. doi: 10.4049/jimmunol.1600676. Epub 2016 Dec 7. J Immunol. 2017. PMID: 27927966
Gliadin peptides activate blood monocytes from patients with celiac disease.
Cinova J, Palová-Jelínková L, Smythies LE, Cerná M, Pecharová B, Dvorák M, Fruhauf P, Tlaskalová-Hogenová H, Smith PD, Tucková L. Cinova J, et al. J Clin Immunol. 2007 Mar;27(2):201-9. doi: 10.1007/s10875-006-9061-z. Epub 2007 Jan 27. J Clin Immunol. 2007. PMID: 17260166
Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-κB signaling pathway and an NLRP3 inflammasome activation.
Palová-Jelínková L, Dáňová K, Drašarová H, Dvořák M, Funda DP, Fundová P, Kotrbová-Kozak A, Černá M, Kamanová J, Martin SF, Freudenberg M, Tučková L. Palová-Jelínková L, et al. PLoS One. 2013 Apr 29;8(4):e62426. doi: 10.1371/journal.pone.0062426. Print 2013. PLoS One. 2013. PMID: 23658628 Free PMC article.
Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis.
Stojanovic I, Dimitrijevic M, Vives-Pi M, Mansilla MJ, Pujol-Autonell I, Rodríguez-Fernandez S, Palova-Jelínkova L, Funda DP, Gruden-Movsesijan A, Sofronic-Milosavljevic L, Hilkens CMU, Martinez-Caceres E, Miljkovic D. Stojanovic I, et al. Curr Pharm Des. 2017;23(18):2623-2643. doi: 10.2174/1381612823666170214120708. Curr Pharm Des. 2017. PMID: 28201972 Review.
High hydrostatic pressure in cancer immunotherapy and biomedicine.
Adkins I, Hradilova N, Palata O, Sadilkova L, Palova-Jelinkova L, Spisek R. Adkins I, et al. Biotechnol Adv. 2018 May-Jun;36(3):577-582. doi: 10.1016/j.biotechadv.2018.01.015. Epub 2018 Feb 1. Biotechnol Adv. 2018. PMID: 29409785 Review.
Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
Funda DP, Goliáš J, Hudcovic T, Kozáková H, Špíšek R, Palová-Jelínková L. Funda DP, et al. Front Immunol. 2018 Feb 16;9:290. doi: 10.3389/fimmu.2018.00290. eCollection 2018. Front Immunol. 2018. PMID: 29503651 Free PMC article.
Radiotherapy in Combination With Cytokine Treatment.
Palata O, Hradilova Podzimkova N, Nedvedova E, Umprecht A, Sadilkova L, Palova Jelinkova L, Spisek R, Adkins I. Palata O, et al. Among authors: palova jelinkova l. Front Oncol. 2019 May 22;9:367. doi: 10.3389/fonc.2019.00367. eCollection 2019. Front Oncol. 2019. PMID: 31179236 Free PMC article. Review.
22 results